Quick Answer
Medinotec Inc. reported Total Revenue of $9.11 million for fiscal year 2025.
Medinotec Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $9.11M +81.5% |
$5.02M +402.3% |
$999.6K | — | — |
| Net Income | $2.16M +633.6% |
-$404.7K -14.7% |
-$352.7K | — | — |
| Total Assets | $6.81M +41.7% |
$4.80M +7.0% |
$4.49M +239.4% |
$1.32M | — |
| Stockholders Equity | $4.27M +97.1% |
$2.17M -15.2% |
$2.56M +643.9% |
-$470.0K -291.4% |
-$120.1K |
| R&D Expense | -$91.1K -307.7% |
-$22.4K +65.5% |
-$64.9K | — | — |
| Operating Income | $3.19M +431.4% |
$600.6K +351.7% |
-$238.6K | — | — |
| Gross Profit | $4.86M +99.0% |
$2.44M +319.8% |
$581.8K | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | November 30, 2025 | $2.54M | -1.1% | -21.6% |
| Net Income | November 30, 2025 | $403.4K | +30.0% | +16.4% |
| Diluted EPS | August 31, 2025 | $0.03 | +50.0% | +200.0% |
| Total Assets | November 30, 2025 | $6.85M | +27.8% | +7.5% |
| Stockholders Equity | November 30, 2025 | $5.50M | +94.6% | +13.7% |
| R&D Expense | November 30, 2025 | $8.3K | -88.0% | -87.4% |
| Operating Income | November 30, 2025 | $552.7K | +4.8% | +4.6% |
| Gross Profit | November 30, 2025 | $1.35M | +29.3% | -32.8% |
| Shares Outstanding | November 30, 2024 | 11.73M | — | +0.0% |
- Medinotec Inc. reported Total Revenue of $9.11 million for fiscal year 2025.
- Medinotec Inc. showed an increase of +81.5% in Total Revenue compared to the prior fiscal year.
- Medinotec Inc. reported Net Income of $2.16 million for fiscal year 2025.
- Medinotec Inc. showed an increase of +633.6% in Net Income compared to the prior fiscal year.
- Medinotec Inc. reported Total Assets of $6.81 million for fiscal year 2025.
- Medinotec Inc. showed an increase of +41.7% in Total Assets compared to the prior fiscal year.
- Medinotec Inc. reported Stockholders Equity of $4.27 million for fiscal year 2025.
- Medinotec Inc. showed an increase of +97.1% in Stockholders Equity compared to the prior fiscal year.
- Medinotec Inc. reported R&D Expense of -$91.1 thousand for fiscal year 2025.
- Medinotec Inc. showed a decrease of -307.7% in R&D Expense compared to the prior fiscal year.
- Medinotec Inc. reported Operating Income of $3.19 million for fiscal year 2025.
- Medinotec Inc. showed an increase of +431.4% in Operating Income compared to the prior fiscal year.
- Medinotec Inc. reported Gross Profit of $4.86 million for fiscal year 2025.
- Medinotec Inc. showed an increase of +99.0% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: